This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: The City University of New York, The State University of New York. Active years: 2015.
Company Filing History:
1 out of 336 
1 out of 2,044 
Years Active: 2015
Title: Hyungsik Lim: Innovator in Drug Screening Technology
Introduction
Hyungsik Lim is a notable inventor based in New York, NY (US). He has made significant contributions to the field of drug screening, particularly through his innovative methods that utilize advanced microscopy techniques. His work is characterized by a focus on retinal tissue, which is crucial for understanding various ocular diseases.
Latest Patents
Hyungsik Lim holds a patent for a "Method for screening a drug in retinal tissue." This patent describes a method that employs second-harmonic generation microscopy to screen drugs effectively. The process involves scanning the tissue with pulsed laser light at an excitation wavelength. The microtubules within the tissue generate light at a second-harmonic wavelength, which is half of the excitation wavelength. By analyzing this generated light, a microtubule pattern within the tissue can be determined, providing valuable insights for drug screening.
Career Highlights
Throughout his career, Hyungsik Lim has worked with prestigious institutions, including The City University of New York and The State University of New York. His experience in these academic environments has allowed him to develop and refine his innovative approaches to drug screening.
Collaborations
Hyungsik Lim has collaborated with various professionals in his field, including his coworker Ioannis Danias. Their joint efforts have contributed to advancements in drug screening methodologies and have furthered research in retinal health.
Conclusion
Hyungsik Lim's contributions to drug screening technology highlight the importance of innovation in medical research. His patented methods offer promising avenues for improving drug efficacy and safety in treating retinal diseases.